Role for monoaminergic systems in the antidepressant-like effect of ethanol extracts from Hemerocallis citrina

J Ethnopharmacol. 2012 Feb 15;139(3):780-7. doi: 10.1016/j.jep.2011.11.059. Epub 2011 Dec 14.

Abstract

Ethnopharmacological relevance: Hemerocallis citrina, a traditional herbal medicine, has been used for the improvement of emotions in Eastern-Asia countries.

Aim of the study: Herein, we explored the antidepressant-like effect and its monoaminergic mechanism of the ethanol extracts from Hemerocallis citrina (HCE).

Materials and methods: Effect of HCE (90, 180 and 360 mg/kg, p.o.) on the immobility time was assessed in the mouse forced swim test (FST) and tail suspension test (TST), and locomotor activity was evaluated in the open-field test (OFT). Additionally, the monoamine neurotransmitters serotonin (5-HT), noradrenaline (NA) and dopamine (DA) levels involved in the antidepressant-like effect of HCE were also measured in the mice brain regions of frontal cortex and hippocampus.

Results: HCE (90, 180 and 360 mg/kg, p.o.) administration significantly reduced the immobility time in both the FST and TST without accompanying changes in locomotor activity in the OFT. The pretreatment of mice with WAY 100635 (0.1 mg/kg, s.c., a 5-HT(1A) receptor antagonist), cyproheptadine (3 mg/kg, i.p., a 5-HT(2) receptor antagonist), prazosin (62.5 μg/kg, i.p., an α(1)-adrenoceptor antagonist), yohimbine (1 mg/kg, i.p., an α(2)-adrenoceptor antagonist), propranolol (5 mg/kg, i.p., a β-adrenoceptor antagonist) or sulpiride (50 mg/kg, i.p., a dopamine D(2) receptor antagonist), but not SCH23390 (0.05 mg/kg, s.c., a dopamine D(1) receptor antagonist) prevented the antidepressant-like effect of HCE (360 mg/kg, p.o.) in the TST. In addition, HCE enhanced 5-HT and NA levels in the frontal cortex and hippocampus as well as elevated DA levels in the frontal cortex.

Conclusion: The results indicate that the antidepressant-like effect of HCE is dependent on the serotonergic (5-HT(1A) and 5-HT(2) receptors), noradrenergic (α(1)-, α(2)- and β-adrenoceptors) and dopaminergic (D(2) receptor) systems as well as the elevation of 5-HT, NA and DA levels in the mouse brain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Agonists / pharmacology
  • Adrenergic Agonists / therapeutic use
  • Adrenergic alpha-Antagonists / pharmacology
  • Adrenergic alpha-Antagonists / therapeutic use
  • Animals
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use*
  • Behavior, Animal / drug effects
  • Brain / metabolism*
  • Depression / drug therapy*
  • Depression / metabolism
  • Dopamine Agents / pharmacology
  • Dopamine Agents / therapeutic use
  • Hemerocallis*
  • Hindlimb Suspension
  • Immobility Response, Tonic / drug effects
  • Locomotion / drug effects
  • Male
  • Mice
  • Mice, Inbred ICR
  • Neurotransmitter Agents / pharmacology
  • Neurotransmitter Agents / therapeutic use*
  • Norepinephrine / metabolism
  • Phytotherapy*
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Receptors, Biogenic Amine / metabolism*
  • Serotonin / metabolism
  • Swimming

Substances

  • Adrenergic Agonists
  • Adrenergic alpha-Antagonists
  • Antidepressive Agents
  • Dopamine Agents
  • Neurotransmitter Agents
  • Plant Extracts
  • Receptors, Biogenic Amine
  • Serotonin
  • Norepinephrine